logo
Share SHARE
FONT-SIZE Plus   Neg

Integra's Flowable Wound Matrix Receives CE Mark Certification

Integra LifeSciences Holdings Corp. (IART) Friday said it has received European CE Mark Certification for its Integra Flowable Wound Matrix, a device used for filling deep soft tissue or tunneling wounds in patients suffering from diabetes.

The device has been recognized by surgeons as one of the most innovative new products available for the management of chronic wounds in diabetic patients, thereby lowering the risk of amputation.

French Society of Reconstructive and Esthetic Plastic Surgery has awarded Integra's Flowable Wound Matrix 1st place in its innovation contest.

Approximately 55 million people in the European Union suffer from diabetes, of which an estimated 3 million will develop a foot ulcer.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT